Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Zalevsky currently holds 9,756 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Zalevsky has been a net seller of NKTR stock. They have purchased $0 and sold $4.8M worth of shares.
Jonathan Zalevsky's most recent insider trade was on Jun 30, 2026, when they sold 5,681 shares at $70.00 per share.
Jonathan Zalevsky serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 45 insider transactions totaling $4.8M over their tenure at the company.
Jonathan Zalevsky holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Jonathan Zalevsky has shown a selling trading pattern, with $0 in total purchases and $4.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan Zalevsky was on May 17, 2021, when they sold $569.3K worth of NKTR shares. This transaction involved 31,111 shares at $18.30 per share.
Jonathan Zalevsky currently owns 9,756 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Zalevsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Zalevsky has 45 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for Jonathan Zalevsky and 40,000+ other insiders.